Global pharmaceutical company Eli Lilly & Co. announced plans to enlarge the scope of its manufacturing plant under construction in the Raleigh-Durham, North Carolina, area because of the rising popularity of its diabetes drugs.
Global pharmaceutical company Eli Lilly & Co. announced plans to enlarge the scope of its manufacturing plant under construction in the Raleigh-Durham, North Carolina, area because of the rising popularity of its diabetes drugs.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In